OQROGet OQRO Pro
Insider trade

Palisade Bio (PALI)Director bought ~$20K

Robert Jr. Baltera, Director at Palisade Bio, bought ~$20K of Palisade Bio shares.

~$20K
Approx. value · 10K sh @ $1.98
367K
Holds after · shares reported
Traded
Jul 2, 2026
Filed
Jul 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jun 10, 2026Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year (and 1 more item)“On June 10, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Palisade Bio, Inc. (the “Company”) expanded the size of the Board from five to six directors and appointed Jordan Zwick to the Board.”
  3. Jul 1, 2026Insider · Their first buy on recordDirector purchased ~$40K of PALI shares in the open market
  4. Jul 2, 2026 · this disclosureInsiderDirector purchased ~$20K of PALI shares in the open market

What came next

  1. Jul 6, 2026InsiderDirector purchased ~$41K of PALI shares in the open market
  2. Jul 7, 2026Insider · 3 peopleInsiders: 1 purchase (~$61K), 2 sales (~$410K)
  3. Jul 8, 2026InsiderDirector purchased ~$40K of PALI shares in the open market
  4. Jul 9, 2026InsiderDirector purchased ~$49K of PALI shares in the open market
  5. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
  6. Oct 1, 2026Insider · Their largest buy since 2023Director purchased ~$14K of PALI shares in the open market
  7. Oct 2, 2026InsiderDirector purchased ~$15K of PALI shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Palisade Bio

For Palisade Bio, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PALI page.

Other recent filings by Robert Jr. Baltera, Director

The full history of Robert Jr. Baltera, Director is on the profile page.

How this filing works

Other disclosures at Palisade Bio

Everything OQRO holds on this company is on its PALI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data